105 related articles for article (PubMed ID: 3039431)
1. Combination chemotherapy of hepatocellular cancer. Comparison of adriamycin + VM 26 + 5-fluorouracil with mAMSA + VM 26 + 5-fluorouracil.
Bezwoda WR; Weaving A; Kew M; Derman DP
Oncology; 1987; 44(4):207-9. PubMed ID: 3039431
[TBL] [Abstract][Full Text] [Related]
2. Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C.
Al-Idrissi HY; Ibrahim EM; Abdel Satir A; Satti MB; Al-Kasem S; Al-Qurain A
Hepatogastroenterology; 1985 Feb; 32(1):8-10. PubMed ID: 2985480
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for advanced hepatocellular carcinoma. Adriamycin versus quadruple chemotherapy.
Choi TK; Lee NW; Wong J
Cancer; 1984 Feb; 53(3):401-5. PubMed ID: 6198058
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
Akçali Z; Akin E; Ozyilkan O
Cancer; 2002 Nov; 95(9):2038-9; author reply 2039. PubMed ID: 12404300
[No Abstract] [Full Text] [Related]
5. [Chemotherapy for hepatocellular carcinoma].
Okusaka T; Ueno H; Ikeda M
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)].
Cavalli F; Tschopp L; Gerber A; Sonntag RW; Ryssel HJ; Brunner KW
Schweiz Med Wochenschr; 1977 Dec; 107(52):1960-6. PubMed ID: 202020
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of malignant hepatomas with sequential intraarterial doxorubicin and systemic 5-fluorouracil and semustine.
O'Connell MJ; Hahn RG; Rubin J; Moertel CG
Cancer; 1988 Sep; 62(6):1041-3. PubMed ID: 2457420
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.
Song MJ; Bae SH; Chun HJ; Choi JY; Yoon SK; Park JY; Han KH; Kim YS; Yim HJ; Um SH; Chung WJ; Hwang JS; Cho SB; Eun JR
Cancer Chemother Pharmacol; 2015 Apr; 75(4):739-46. PubMed ID: 25663125
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
Leung TW; Tang AM; Zee B; Yu SC; Lai PB; Lau WY; Johnson PJ
Cancer; 2002 Jan; 94(2):421-7. PubMed ID: 11905412
[TBL] [Abstract][Full Text] [Related]
10. Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas.
O'Connell MJ; Anderson J; Merrill JM; Bennett JM; Glick JH; Berard CW; Neiman RS; Brodovsky HS
Cancer Treat Rep; 1982 Dec; 66(12):2021-5. PubMed ID: 6814757
[TBL] [Abstract][Full Text] [Related]
11. Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin.
Melia WM; Johnson PJ; Williams R
Cancer; 1983 Jan; 51(2):206-10. PubMed ID: 6295596
[TBL] [Abstract][Full Text] [Related]
12. VM-26 and dimethyl triazeno imidazole carboxamide in Ewing's sarcoma.
Campbell AM; Ekert H; Waters KD
Aust Paediatr J; 1983 Mar; 19(1):30-3. PubMed ID: 6347162
[TBL] [Abstract][Full Text] [Related]
13. [A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
Buge A; Poisson M; Pouillart P
Rev Neurol (Paris); 1978 May; 134(5):369-77. PubMed ID: 364592
[TBL] [Abstract][Full Text] [Related]
14. Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study.
Eur Urol; 1976; 2(3):138-41. PubMed ID: 70352
[TBL] [Abstract][Full Text] [Related]
15. Systemic cytotoxic chemotherapy of patients with advanced hepatocellular carcinoma in the era of sorafenib nonavailability.
Yoon EL; Yeon JE; Lee HJ; Suh SJ; Lee SJ; Kang SH; Kang K; Yoo YJ; Kim JH; Yim HJ; Byun KS
J Clin Gastroenterol; 2014 Mar; 48(3):e22-9. PubMed ID: 24045282
[TBL] [Abstract][Full Text] [Related]
16. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.
Leung TW; Patt YZ; Lau WY; Ho SK; Yu SC; Chan AT; Mok TS; Yeo W; Liew CT; Leung NW; Tang AM; Johnson PJ
Clin Cancer Res; 1999 Jul; 5(7):1676-81. PubMed ID: 10430068
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].
Ishibashi T; Okajima K; Isozaki H; Morita S; Nakata E; Nishimura J; Iga C; Amioka K; Tanimura M; Hara H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2778-81. PubMed ID: 2551222
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of chemotherapy in hepatocellular carcinoma with liver cirrhosis].
Munehisa T; Tajima H; Goto M; Nakata K; Muro T; Kawahara K; Kohno K; Sato A; Furukawa R; Ogino T
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2318-23. PubMed ID: 6314913
[TBL] [Abstract][Full Text] [Related]
19. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.
Yeo W; Mok TS; Zee B; Leung TW; Lai PB; Lau WY; Koh J; Mo FK; Yu SC; Chan AT; Hui P; Ma B; Lam KC; Ho WM; Wong HT; Tang A; Johnson PJ
J Natl Cancer Inst; 2005 Oct; 97(20):1532-8. PubMed ID: 16234567
[TBL] [Abstract][Full Text] [Related]
20. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study.
Friedman MA; Volberding PA; Cassidy MJ; Resser KJ; Wasserman TH; Phillips TL
Cancer Treat Rep; 1979; 63(11-12):1885-8. PubMed ID: 230895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
